GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CPIX · Sep 30, 2020

CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628280-20-016446General Corporate
Inventory pressure85thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

108.97% · OPTIONAL · VALID

Gross margin20thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

76.84% · CORE · VALID

Operating margin45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

-13.07% · CORE · VALID

R&D intensity50thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

13.30% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History61 statesSelf-history eligible
Period transition

What moved in the state?

Inventory Pressure Increased
Previous
79.47%
Current
108.97%
Delta
29.50%
Margin Increased
Previous
72.81%
Current
76.84%
Delta
4.03%
Profitability Increased
Previous
-16.47%
Current
-13.07%
Delta
3.41%
R And D Intensity Decreased
Previous
14.81%
Current
13.30%
Delta
-1.51%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.